Robert Alexander Allakos Inc. (ALLK) insider trading activity

Robert Alexander is Chief Executive Officer of Allakos Inc.. Currently has a direct ownership of 801,940 shares of ALLK, which is worth approximately $713,726. The most recent transaction as insider was on May 19, 2021, when has been sold 14,516 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $10,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 802K

4.1% 3M change

17.02% 12M change

Total Value Held $713,726

Robert Alexander Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2021	BUY Exercise of conversion of derivative security	$10,016 $0.69 p/Share	14,516 Added 5.29%	259,911 Common Stock
May 18 2021	SELL Open market or private sale	$1,485,379 $102.32 p/Share	14,517 Reduced 5.59%	245,395 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$10,017 $0.69 p/Share	14,517 Added 5.29%	259,912 Common Stock
May 17 2021	SELL Open market or private sale	$1,447,055 $99.68 p/Share	14,517 Reduced 5.59%	245,395 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$10,017 $0.69 p/Share	14,517 Added 5.29%	259,912 Common Stock
Mar 17 2021	SELL Open market or private sale	$2,422,800 $121.14 p/Share	20,000 Reduced 7.54%	245,395 Common Stock
Mar 17 2021	BUY Exercise of conversion of derivative security	$13,800 $0.69 p/Share	20,000 Added 7.01%	265,395 Common Stock
Mar 16 2021	SELL Open market or private sale	$2,435,200 $121.76 p/Share	20,000 Reduced 7.54%	245,395 Common Stock
Mar 16 2021	BUY Exercise of conversion of derivative security	$13,800 $0.69 p/Share	20,000 Added 7.01%	265,395 Common Stock
Mar 15 2021	SELL Open market or private sale	$2,455,600 $122.78 p/Share	20,000 Reduced 7.54%	245,395 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$13,800 $0.69 p/Share	20,000 Added 7.01%	265,395 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$458,320 $117.82 p/Share	3,890 Reduced 1.56%	245,395 Common Stock
Dec 29 2020	BUY Exercise of conversion of derivative security	$35,514 $4.31 p/Share	8,240 Added 3.3%	241,105 Common Stock
Dec 02 2020	SELL Payment of exercise price or tax liability	$1,436,179 $99.04 p/Share	14,501 Reduced 5.86%	232,865 Common Stock
Dec 01 2020	BUY Grant, award, or other acquisition	-	121,600 Added 32.96%	247,366 Common Stock

Also insider at

ALNA

Allena Pharmaceuticals, Inc. Healthcare

Director